× Vous devez vous connecter pour voir toutes les infos de l'adhérent et utiliser le formulaire de contact.


  • Type Start-up

À propos

Founded in 2019, Imescia is a spin-off company from the Institut Galien Paris-Sud, co-founded by Tanguy Boissenot CEO (Pharm.D., Ph.D.), Alexandre Bordat CTO (Ecole polytechnique, Ph.D.), Nicolas Tsapis (Ph.D., CNRS researcher), and Julien Nicolas (Ph.D., CNRS researcher). The company is the result of four years of fundamental research at the Institut Galien Paris-Sud.

The team has the expertise in polymer synthesis and drug delivery systems.